Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
POLA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CDC42EP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIGD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAPN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A45 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FRMD8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6751 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL49 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAU - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNHIT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TM7SF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on